{
    "2023-06-30": {
        "Tax Effect Of Unusual Items": 0.0,
        "Tax Rate For Calcs": 0.173228,
        "Normalized EBITDA": 152000000.0,
        "Total Unusual Items": 0.0,
        "Total Unusual Items Excluding Goodwill": 0.0,
        "Net Income From Continuing Operation Net Minority Interest": 105000000.0,
        "Reconciled Depreciation": 41000000.0,
        "Reconciled Cost Of Revenue": 31000000.0,
        "EBITDA": 152000000.0,
        "EBIT": 111000000.0,
        "Net Interest Income": 24000000.0,
        "Interest Income": 24000000.0,
        "Normalized Income": 105000000.0,
        "Net Income From Continuing And Discontinued Operation": 105000000.0,
        "Total Expenses": 564000000.0,
        "Total Operating Income As Reported": 111000000.0,
        "Diluted Average Shares": 1026054856.0,
        "Basic Average Shares": 1026054856.0,
        "Diluted EPS": 0.102334,
        "Basic EPS": 0.102334,
        "Diluted NI Availto Com Stockholders": 105000000.0,
        "Net Income Common Stockholders": 105000000.0,
        "Net Income": 105000000.0,
        "Net Income Including Noncontrolling Interests": 105000000.0,
        "Net Income Continuous Operations": 105000000.0,
        "Tax Provision": 22000000.0,
        "Pretax Income": 127000000.0,
        "Other Income Expense": -8000000.0,
        "Other Non Operating Income Expenses": -1000000.0,
        "Special Income Charges": 0.0,
        "Impairment Of Capital Assets": 0.0,
        "Restructuring And Mergern Acquisition": 0.0,
        "Earnings From Equity Interest": -7000000.0,
        "Net Non Operating Interest Income Expense": 24000000.0,
        "Interest Income Non Operating": 24000000.0,
        "Operating Income": 111000000.0,
        "Operating Expense": 533000000.0,
        "Research And Development": 337000000.0,
        "Selling General And Administration": 196000000.0,
        "Gross Profit": 644000000.0,
        "Cost Of Revenue": 31000000.0,
        "Total Revenue": 675000000.0,
        "Operating Revenue": 675000000.0
    },
    "2022-06-30": {
        "Tax Effect Of Unusual Items": -426573.426573,
        "Tax Rate For Calcs": 0.213287,
        "Normalized EBITDA": 340000000.0,
        "Total Unusual Items": -2000000.0,
        "Total Unusual Items Excluding Goodwill": -2000000.0,
        "Net Income From Continuing Operation Net Minority Interest": 225000000.0,
        "Reconciled Depreciation": 42000000.0,
        "Reconciled Cost Of Revenue": 25000000.0,
        "EBITDA": 338000000.0,
        "EBIT": 296000000.0,
        "Net Interest Income": 2000000.0,
        "Interest Income": 2000000.0,
        "Normalized Income": 226573426.573427,
        "Net Income From Continuing And Discontinued Operation": 225000000.0,
        "Total Expenses": 396000000.0,
        "Total Operating Income As Reported": 294000000.0,
        "Diluted NI Availto Com Stockholders": 225000000.0,
        "Net Income Common Stockholders": 225000000.0,
        "Net Income": 225000000.0,
        "Net Income Including Noncontrolling Interests": 225000000.0,
        "Net Income Continuous Operations": 225000000.0,
        "Tax Provision": 61000000.0,
        "Pretax Income": 286000000.0,
        "Other Income Expense": -12000000.0,
        "Other Non Operating Income Expenses": 4000000.0,
        "Special Income Charges": -2000000.0,
        "Impairment Of Capital Assets": 0.0,
        "Restructuring And Mergern Acquisition": 2000000.0,
        "Earnings From Equity Interest": -14000000.0,
        "Net Non Operating Interest Income Expense": 2000000.0,
        "Interest Income Non Operating": 2000000.0,
        "Operating Income": 296000000.0,
        "Operating Expense": 371000000.0,
        "Research And Development": 218000000.0,
        "Selling General And Administration": 153000000.0,
        "Gross Profit": 667000000.0,
        "Cost Of Revenue": 25000000.0,
        "Total Revenue": 692000000.0,
        "Operating Revenue": 692000000.0
    },
    "2023-09-30": {
        "Tax Effect Of Unusual Items": 0.0,
        "Tax Rate For Calcs": 0.076,
        "Normalized EBITDA": -115000000.0,
        "Total Unusual Items": 0.0,
        "Total Unusual Items Excluding Goodwill": 0.0,
        "Net Income From Continuing Operation Net Minority Interest": -110000000.0,
        "Reconciled Depreciation": 41000000.0,
        "Reconciled Cost Of Revenue": 46000000.0,
        "EBITDA": -115000000.0,
        "EBIT": -156000000.0,
        "Net Interest Income": 28000000.0,
        "Interest Income": 28000000.0,
        "Normalized Income": -110000000.0,
        "Net Income From Continuing And Discontinued Operation": -110000000.0,
        "Total Expenses": 962000000.0,
        "Total Operating Income As Reported": -156000000.0,
        "Diluted Average Shares": 1025312845.0,
        "Basic Average Shares": 1025312845.0,
        "Diluted EPS": -0.11,
        "Basic EPS": -0.11,
        "Diluted NI Availto Com Stockholders": -110000000.0,
        "Net Income Common Stockholders": -110000000.0,
        "Net Income": -110000000.0,
        "Net Income Including Noncontrolling Interests": -110000000.0,
        "Net Income Continuous Operations": -110000000.0,
        "Tax Provision": -9000000.0,
        "Pretax Income": -119000000.0,
        "Other Income Expense": 9000000.0,
        "Other Non Operating Income Expenses": 14000000.0,
        "Special Income Charges": 0.0,
        "Impairment Of Capital Assets": NaN,
        "Restructuring And Mergern Acquisition": 0.0,
        "Earnings From Equity Interest": -5000000.0,
        "Net Non Operating Interest Income Expense": 28000000.0,
        "Interest Income Non Operating": 28000000.0,
        "Operating Income": -156000000.0,
        "Operating Expense": 916000000.0,
        "Research And Development": 626000000.0,
        "Selling General And Administration": 290000000.0,
        "Gross Profit": 760000000.0,
        "Cost Of Revenue": 46000000.0,
        "Total Revenue": 806000000.0,
        "Operating Revenue": 806000000.0
    },
    "2022-09-30": {
        "Tax Effect Of Unusual Items": -500000.0,
        "Tax Rate For Calcs": 0.25,
        "Normalized EBITDA": 232000000.0,
        "Total Unusual Items": -2000000.0,
        "Total Unusual Items Excluding Goodwill": -2000000.0,
        "Net Income From Continuing Operation Net Minority Interest": 114000000.0,
        "Reconciled Depreciation": 45000000.0,
        "Reconciled Cost Of Revenue": 25000000.0,
        "EBITDA": 230000000.0,
        "EBIT": 185000000.0,
        "Net Interest Income": 6000000.0,
        "Interest Income": 6000000.0,
        "Normalized Income": 115500000.0,
        "Net Income From Continuing And Discontinued Operation": 114000000.0,
        "Total Expenses": 445000000.0,
        "Total Operating Income As Reported": 183000000.0,
        "Diluted Average Shares": 1026054856.0,
        "Basic Average Shares": 1026054856.0,
        "Diluted EPS": 0.111105,
        "Basic EPS": 0.111105,
        "Diluted NI Availto Com Stockholders": 114000000.0,
        "Net Income Common Stockholders": 114000000.0,
        "Net Income": 114000000.0,
        "Net Income Including Noncontrolling Interests": 114000000.0,
        "Net Income Continuous Operations": 114000000.0,
        "Tax Provision": 38000000.0,
        "Pretax Income": 152000000.0,
        "Other Income Expense": -39000000.0,
        "Other Non Operating Income Expenses": 23000000.0,
        "Special Income Charges": -2000000.0,
        "Impairment Of Capital Assets": NaN,
        "Restructuring And Mergern Acquisition": 2000000.0,
        "Earnings From Equity Interest": -60000000.0,
        "Net Non Operating Interest Income Expense": 6000000.0,
        "Interest Income Non Operating": 6000000.0,
        "Operating Income": 185000000.0,
        "Operating Expense": 420000000.0,
        "Research And Development": 248000000.0,
        "Selling General And Administration": 172000000.0,
        "Gross Profit": 605000000.0,
        "Cost Of Revenue": 25000000.0,
        "Total Revenue": 630000000.0,
        "Operating Revenue": 630000000.0
    },
    "2023-12-31": {
        "Tax Effect Of Unusual Items": -1140000.0,
        "Tax Rate For Calcs": 0.19,
        "Normalized EBITDA": 188000000.0,
        "Total Unusual Items": -6000000.0,
        "Total Unusual Items Excluding Goodwill": -6000000.0,
        "Net Income From Continuing Operation Net Minority Interest": 87000000.0,
        "Reconciled Depreciation": 42000000.0,
        "Reconciled Cost Of Revenue": 36000000.0,
        "EBITDA": 182000000.0,
        "EBIT": 140000000.0,
        "Net Interest Income": 28000000.0,
        "Interest Income": 28000000.0,
        "Normalized Income": 91860000.0,
        "Net Income From Continuing And Discontinued Operation": 87000000.0,
        "Total Expenses": 684000000.0,
        "Total Operating Income As Reported": 134000000.0,
        "Diluted Average Shares": 1048888489.0,
        "Basic Average Shares": 1026894266.0,
        "Diluted EPS": 0.08,
        "Basic EPS": 0.08,
        "Diluted NI Availto Com Stockholders": 87000000.0,
        "Net Income Common Stockholders": 87000000.0,
        "Net Income": 87000000.0,
        "Net Income Including Noncontrolling Interests": 87000000.0,
        "Net Income Continuous Operations": 87000000.0,
        "Tax Provision": 59000000.0,
        "Pretax Income": 146000000.0,
        "Other Income Expense": -22000000.0,
        "Other Non Operating Income Expenses": -15000000.0,
        "Special Income Charges": -6000000.0,
        "Impairment Of Capital Assets": NaN,
        "Restructuring And Mergern Acquisition": 6000000.0,
        "Earnings From Equity Interest": -1000000.0,
        "Net Non Operating Interest Income Expense": 28000000.0,
        "Interest Income Non Operating": 28000000.0,
        "Operating Income": 140000000.0,
        "Operating Expense": 648000000.0,
        "Research And Development": 432000000.0,
        "Selling General And Administration": 216000000.0,
        "Gross Profit": 788000000.0,
        "Cost Of Revenue": 36000000.0,
        "Total Revenue": 824000000.0,
        "Operating Revenue": 824000000.0
    },
    "2023-03-31": {
        "Tax Effect Of Unusual Items": -400000.0,
        "Tax Rate For Calcs": 0.4,
        "Normalized EBITDA": -8000000.0,
        "Total Unusual Items": -1000000.0,
        "Total Unusual Items Excluding Goodwill": -1000000.0,
        "Net Income From Continuing Operation Net Minority Interest": 3000000.0,
        "Reconciled Depreciation": 40000000.0,
        "Reconciled Cost Of Revenue": 27000000.0,
        "EBITDA": -9000000.0,
        "EBIT": -49000000.0,
        "Net Interest Income": 21000000.0,
        "Interest Income": 21000000.0,
        "Normalized Income": 3600000.0,
        "Net Income From Continuing And Discontinued Operation": 3000000.0,
        "Total Expenses": 682000000.0,
        "Total Operating Income As Reported": -50000000.0,
        "Diluted Average Shares": NaN,
        "Basic Average Shares": NaN,
        "Diluted EPS": NaN,
        "Basic EPS": NaN,
        "Diluted NI Availto Com Stockholders": 3000000.0,
        "Net Income Common Stockholders": 3000000.0,
        "Net Income": 3000000.0,
        "Net Income Including Noncontrolling Interests": 3000000.0,
        "Net Income Continuous Operations": 3000000.0,
        "Tax Provision": 2000000.0,
        "Pretax Income": 5000000.0,
        "Other Income Expense": 33000000.0,
        "Other Non Operating Income Expenses": -1000000.0,
        "Special Income Charges": -1000000.0,
        "Impairment Of Capital Assets": NaN,
        "Restructuring And Mergern Acquisition": 1000000.0,
        "Earnings From Equity Interest": 35000000.0,
        "Net Non Operating Interest Income Expense": 21000000.0,
        "Interest Income Non Operating": 21000000.0,
        "Operating Income": -49000000.0,
        "Operating Expense": 655000000.0,
        "Research And Development": 381000000.0,
        "Selling General And Administration": 274000000.0,
        "Gross Profit": 606000000.0,
        "Cost Of Revenue": 27000000.0,
        "Total Revenue": 633000000.0,
        "Operating Revenue": 633000000.0
    },
    "2022-12-31": {
        "Tax Effect Of Unusual Items": -403508.77193,
        "Tax Rate For Calcs": 0.201754,
        "Normalized EBITDA": 291000000.0,
        "Total Unusual Items": -2000000.0,
        "Total Unusual Items Excluding Goodwill": -2000000.0,
        "Net Income From Continuing Operation Net Minority Interest": 182000000.0,
        "Reconciled Depreciation": 43000000.0,
        "Reconciled Cost Of Revenue": 29000000.0,
        "EBITDA": 289000000.0,
        "EBIT": 246000000.0,
        "Net Interest Income": 13000000.0,
        "Interest Income": 13000000.0,
        "Normalized Income": 183596491.22807,
        "Net Income From Continuing And Discontinued Operation": 182000000.0,
        "Total Expenses": 478000000.0,
        "Total Operating Income As Reported": 244000000.0,
        "Diluted Average Shares": 1026054856.0,
        "Basic Average Shares": 1026054856.0,
        "Diluted EPS": 0.177378,
        "Basic EPS": 0.177378,
        "Diluted NI Availto Com Stockholders": 182000000.0,
        "Net Income Common Stockholders": 182000000.0,
        "Net Income": 182000000.0,
        "Net Income Including Noncontrolling Interests": 182000000.0,
        "Net Income Continuous Operations": 182000000.0,
        "Tax Provision": 46000000.0,
        "Pretax Income": 228000000.0,
        "Other Income Expense": -31000000.0,
        "Other Non Operating Income Expenses": -23000000.0,
        "Special Income Charges": -2000000.0,
        "Impairment Of Capital Assets": NaN,
        "Restructuring And Mergern Acquisition": 2000000.0,
        "Earnings From Equity Interest": -6000000.0,
        "Net Non Operating Interest Income Expense": 13000000.0,
        "Interest Income Non Operating": 13000000.0,
        "Operating Income": 246000000.0,
        "Operating Expense": 449000000.0,
        "Research And Development": 286000000.0,
        "Selling General And Administration": 163000000.0,
        "Gross Profit": 695000000.0,
        "Cost Of Revenue": 29000000.0,
        "Total Revenue": 724000000.0,
        "Operating Revenue": 724000000.0
    }
}